[go: up one dir, main page]

GB0411571D0 - Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis - Google Patents

Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis

Info

Publication number
GB0411571D0
GB0411571D0 GBGB0411571.3A GB0411571A GB0411571D0 GB 0411571 D0 GB0411571 D0 GB 0411571D0 GB 0411571 A GB0411571 A GB 0411571A GB 0411571 D0 GB0411571 D0 GB 0411571D0
Authority
GB
United Kingdom
Prior art keywords
acellular
bacillus anthracis
compositions
against bacillus
immunogenic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0411571.3A
Other versions
GB2398242A (en
GB2398242B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9911384A external-priority patent/FR2798291B1/en
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur filed Critical Centre National de la Recherche Scientifique CNRS
Publication of GB0411571D0 publication Critical patent/GB0411571D0/en
Publication of GB2398242A publication Critical patent/GB2398242A/en
Application granted granted Critical
Publication of GB2398242B publication Critical patent/GB2398242B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1278—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB0411571A 1999-09-10 2000-09-08 Bacillus anthracis strain Expired - Fee Related GB2398242B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911384A FR2798291B1 (en) 1999-09-10 1999-09-10 IMMUNOGENIC ACELLULAR COMPOSITIONS AND VACCINE ACELLULAR COMPOSITIONS AGAINST BACILLUS ANTHRACIS
GB0207118A GB2370772B (en) 1999-09-10 2000-09-08 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis

Publications (3)

Publication Number Publication Date
GB0411571D0 true GB0411571D0 (en) 2004-06-23
GB2398242A GB2398242A (en) 2004-08-18
GB2398242B GB2398242B (en) 2004-10-20

Family

ID=32737537

Family Applications (3)

Application Number Title Priority Date Filing Date
GB0414537A Expired - Fee Related GB2400559B (en) 1999-09-10 2000-09-08 Bacillus anthracis exoantigens
GB0411571A Expired - Fee Related GB2398242B (en) 1999-09-10 2000-09-08 Bacillus anthracis strain
GB0414534A Expired - Fee Related GB2400558B (en) 1999-09-10 2000-09-08 Passive immunisation against bacillus anthracis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB0414537A Expired - Fee Related GB2400559B (en) 1999-09-10 2000-09-08 Bacillus anthracis exoantigens

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0414534A Expired - Fee Related GB2400558B (en) 1999-09-10 2000-09-08 Passive immunisation against bacillus anthracis

Country Status (1)

Country Link
GB (3) GB2400559B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676068B1 (en) * 1991-05-02 1994-11-04 Pasteur Institut IMMUNOGENIC RECOMBINANT STRAINS OF B. ANTHRACIS - IMMUNOGENIC COMPOSITIONS CONTAINING THEM.
EP0739981A1 (en) * 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes

Also Published As

Publication number Publication date
GB2400558A (en) 2004-10-20
GB2400559A (en) 2004-10-20
GB0414537D0 (en) 2004-08-04
GB2400558B (en) 2004-12-15
GB2398242A (en) 2004-08-18
GB2398242B (en) 2004-10-20
GB0414534D0 (en) 2004-08-04
GB2400559B (en) 2004-12-01

Similar Documents

Publication Publication Date Title
AP2001002300A0 (en) Hiv immunogenic compositions and methods
PL392363A1 (en) Vaccine formulation
IL148456A0 (en) Combined vaccine compositions
EP1420829A4 (en) Immunomodulatory compositions, formulations, and methods for use thereof
GB2370772B (en) Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis
HUP0301413A3 (en) Vaccine compositions
IL148247A (en) Vaccine composition and uses thereof
HUP0302117A3 (en) Vaccine composition
IL151942A0 (en) Compositions and methods for enhancing immunogenicity of antigens
GB0020089D0 (en) Vaccine Composition
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
GB9910812D0 (en) Vaccine composition
AU2151902A (en) Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
AU5577201A (en) Immunogenic pneumococcal protein and vaccine compositions thereof
AU9567201A (en) Vaccine composition and stabilisation method
AU2001295672A1 (en) Vaccine composition and stabilisation method
GB0411571D0 (en) Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis
AU1101701A (en) Vaccine compositions
GB9921347D0 (en) Novel immunogenic compositions
GB9922561D0 (en) Neisserial vaccine compositions and methods
GB9929434D0 (en) Novel vaccine composition
AU3513500A (en) Emulsan and emulsan analogs immunization formulations and use
GB9930460D0 (en) Vaccine compositions
GB9930458D0 (en) Vaccine compositions
GB9930456D0 (en) Vaccine compositions

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1066027

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1066027

Country of ref document: HK

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120908